Noscendo
GermanyWho owns Noscendo?
Noscendo is a German MedTech company, now owned by Bruker, which acquired it in 2026 from SquareOne.
Earlybird Venture Capital is still listed as an investor in Noscendo, status not confirmed after the 2026 sale.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Key facts
- ·Held by Earlybird Venture Capital since 2022 (4Y hold).
- ·Average hold across 2 realized cycles: 5 years.
Ownership history
3 ownership periods · co-invest detected
SquareOne sold Noscendo to Bruker in 2026 after 6 years.
Revent exited Noscendo in 2026 after 4 years.
More from Earlybird Health
Other portfolio companies in the same fund.
UK
Switzerland
USMore PE-backed in MedTech
Comparable medtech deals from other GPs.
Questions
Who owns Noscendo?
Noscendo is now owned by Bruker, which acquired it in 2026 from SquareOne. Earlybird Venture Capital is still listed as an investor in Noscendo, status not confirmed after the 2026 sale.
When did Bruker acquire Noscendo?
Bruker acquired Noscendo in 2026, buying from SquareOne.
Who did Noscendo sell to?
SquareOne sold Noscendo to Bruker in 2026 (Trade Sale).
Who has owned Noscendo over time?
Noscendo has been through 3 private-equity ownership periods: SquareOne · via Paua Ventures Fund I · 2020–2026 · sold to Bruker · (Trade Sale); Earlybird Venture Capital · via Earlybird Health · since 2022; Revent · via Revent Fund I · 2022–2026.